SCHEMBL2877321

SCHEMBL2877321

CC(N)OC(=O)C(O)C(O)(C(=O)O)c1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.46
LMNA P02545 1/20 0.46
ADRA2B P18089 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2B P41595 1/20 0.46
KCNH2 Q12809 1/20 0.46
POLB P06746 2/20 0.34
ALKBH5 Q6P6C2 1/20 0.34
HTR1B P28222 2/20 0.33
HTR1D P28221 1/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
CYP2C9 P11712 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TSHR P16473 2/20 0.32
HPGD P15428 1/20 0.32
GABRA1 P14867 2/20 0.32
GABRB2 P47870 2/20 0.32
GABRB1 P18505 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881897 0.84 LMNA (0.47) HTR1ALMNAADRA2BHTR2AHTR2B
SCHEMBL2788593 0.76 LMNA (0.51) HTR1ALMNAADRA2BHTR2AHTR2B
SCHEMBL2788456 0.75 LMNA (0.48) HTR1ALMNAADRA2BHTR2AHTR2B
SCHEMBL2880030 0.75 LMNA (0.47) HTR1ALMNAADRA2BHTR2AHTR2B
SCHEMBL189975 0.73 HTR1A (0.58) HTR1ALMNAADRA2BHTR2AHTR2B
SCHEMBL2789287 0.71 HTR1A (0.58) HTR1ALMNAADRA2BHTR2AHTR2B
SCHEMBL13081207 0.69 LMNA (0.66) HTR1ALMNAADRA2BHTR2AHTR2B
Cadaverine Tartrate SCHEMBL2877318 0.69 HTR1A (0.63) HTR1ALMNAADRA2BHTR2AHTR2B
SCHEMBL189974 0.68 HTR1A (0.68) HTR1ALMNAADRA2BHTR2AHTR2B
Oxalic Acid SCHEMBL2788592 0.68 HTR1A (0.67) HTR1ALMNAADRA2BHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010113183-A2 PROCESS FOR THE PREPARATION OF 1-[[[3-[2-(DIMETHYLAMINO)ETHYL]-1H-INDOL-5-YL]METHYL]SULFONYL] PYRROLIDINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS MSN LABORATORIES LIMITED (IN) 2010-10-07 WO disclosed